Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-α on renal cell carcinoma cell lines by protein biochip technology

  • Authors:
    • Kogenta Nakamura
    • Kazuhiro Yoshikawa
    • Yoshiaki Yamada
    • Shinsuke Saga
    • Shigeyuki Aoki
    • Tomohiro Taki
    • Motoi Tobiume
    • Toru Shimazui
    • Hideyuki Akaza
    • Nobuaki Honda
  • View Affiliations

  • Published online on: April 1, 2006     https://doi.org/10.3892/ijo.28.4.965
  • Pages: 965-970
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Interferon-α (IFN) is widely used for the treatment of progressive renal cell carcinoma (RCC), but its effective response rate is only about 15%. New biomarkers of RCC contributing to the effective IFN treatment are needed to establish a sensitivity test for evaluating if the IFN is effective or not against RCC. All the proteins expressed in the IFN-susceptible and -resistant RCC cell lysates were analyzed by surface enhanced laser desorption inonization (SELDI) mass spectrometry using ProteinChip® technology and their different protein expression were detected by the comparison of the profiles between them. We detected the following candidate markers that exhibited peak shifts: a) in the IFN-susceptible cell lines, a candidate marker with a molecular weight of 5688 Da was detected on a hydrophobic (H4) chip: b) in the IFN-resistant cell lines, candidate markers each with a molecular weight of 8049, 3157, 3993, and 8959 Da were detected on strong anion exchange (SAX2, pH 9.0, two types) chips, H4 chip, and weak cation exchange (WCX, pH 9.0) chips, respectively. IFN treatment produced no weight increase in these four proteins, and c) candidate marker with a molecular weight of 1623 Da that was expressed in both cell lines after the IFN treatment was detected on the H4 chip. These data suggest that the ProteinChip system is very useful in identifying proteins showing unique peaks in the RCC cell lines with different IFN susceptibility, and the comparison of these proteins measured in RCC cell lysates may help to identify the IFN sensitivity. Furthermore, the discovery of a susceptibility and or a inhibitory factor may eventually lead to the development of a novel drug targeting the respective factor for the improvement of anticancer chemotherapy.

Related Articles

Journal Cover

April 2006
Volume 28 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Nakamura, K., Yoshikawa, K., Yamada, Y., Saga, S., Aoki, S., Taki, T. ... Honda, N. (2006). Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-α on renal cell carcinoma cell lines by protein biochip technology. International Journal of Oncology, 28, 965-970. https://doi.org/10.3892/ijo.28.4.965
MLA
Nakamura, K., Yoshikawa, K., Yamada, Y., Saga, S., Aoki, S., Taki, T., Tobiume, M., Shimazui, T., Akaza, H., Honda, N."Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-α on renal cell carcinoma cell lines by protein biochip technology". International Journal of Oncology 28.4 (2006): 965-970.
Chicago
Nakamura, K., Yoshikawa, K., Yamada, Y., Saga, S., Aoki, S., Taki, T., Tobiume, M., Shimazui, T., Akaza, H., Honda, N."Differential profiling analysis of proteins involved in anti-proliferative effect of interferon-α on renal cell carcinoma cell lines by protein biochip technology". International Journal of Oncology 28, no. 4 (2006): 965-970. https://doi.org/10.3892/ijo.28.4.965